Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Resmed ( (RMD) ) has provided an update.
On January 29, 2026, Resmed’s board declared a quarterly cash dividend of US$0.60 per share, payable March 19, 2026, to shareholders of record on February 12, 2026, with payments made in U.S. dollars for NYSE-listed common stock and in Australian dollars for CHESS Depositary Instrument holders on the ASX, reflecting the 10:1 CDI-to-share ratio and a temporary waiver to defer stock-to-CDI conversions around the ex-dividend date. On the same day, the company reported strong results for the quarter ended December 31, 2025, with revenue up 11% to US$1.42 billion (9% in constant currency), gross margin expanding to 61.8%, income from operations rising 18%, and diluted EPS increasing 15% to US$2.68, underpinned by robust demand for its sleep and respiratory devices, growing contribution from its digital health platform, and solid cash generation, reinforcing its positioning for continued investment-led yet profitable growth in the second half of fiscal 2026.
The most recent analyst rating on (RMD) stock is a Buy with a $300.00 price target. To see the full list of analyst forecasts on Resmed stock, see the RMD Stock Forecast page.
Spark’s Take on RMD Stock
According to Spark, TipRanks’ AI Analyst, RMD is a Outperform.
Resmed’s strong financial performance and positive earnings call are the primary drivers of its overall score. The company’s robust revenue growth and strategic expansions are significant strengths. However, technical indicators suggest caution, and the high P/E ratio reflects a premium valuation, which may limit upside potential.
To see Spark’s full report on RMD stock, click here.
More about Resmed
Resmed Inc. is a global medical technology company focused on sleep and respiratory care, providing devices and a digital health ecosystem that supports patients in more than 140 countries to help them sleep better, breathe better, and receive care at home.
Average Trading Volume: 1,038,478
Technical Sentiment Signal: Buy
Current Market Cap: $37.29B
For a thorough assessment of RMD stock, go to TipRanks’ Stock Analysis page.